Heat shock protein 90 inhibitors in non-small-cell lung cancer
RN Pillai, SS Ramalingam - Current opinion in oncology, 2014 - journals.lww.com
RN Pillai, SS Ramalingam
Current opinion in oncology, 2014•journals.lww.comHeat shock protein 90 inhibitors in non-small-cell lung canc... : Current Opinion in Oncology
Heat shock protein 90 inhibitors in non-small-cell lung cancer : Current Opinion in Oncology
Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary
Logo Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles &
Issues For Authors Journal Info Advanced Search March 2014 - Volume 26 - Issue 2 Previous
Article Next Article LUNG AND MEDIASTINUM: Edited by Robert Pirker Heat shock protein 90 …
Heat shock protein 90 inhibitors in non-small-cell lung cancer : Current Opinion in Oncology
Log in or Register Subscribe to journalSubscribe Get new issue alertsGet alerts Secondary
Logo Journal Logo Advanced Search Toggle navigation Subscribe Register Login Articles &
Issues For Authors Journal Info Advanced Search March 2014 - Volume 26 - Issue 2 Previous
Article Next Article LUNG AND MEDIASTINUM: Edited by Robert Pirker Heat shock protein 90 …
Summary
Preclinical studies and early clinical trials have confirmed the efficacy of Hsp90 inhibition as a targeted therapy in NSCLC. Ongoing trials will further define the utility of Hsp90 inhibitors in NSCLC.
Lippincott Williams & Wilkins